Eton Pharmaceuticals, Inc.

ETON · Healthcare · Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases

Eton Pharmaceuticals, Inc. (ETON), in the Healthcare sector, has 10 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 10 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 28 and filed Aug 31. The most active filer was Opaleye Management Inc. with 4 filings.

Add to watchlist

Filings, ttm

0 buys · 10 sells · 1 late

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$29.2M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 28

Filed Aug 31

ADViAverage daily dollar volume

$33.1M

market data

Share price · 12M

$58.45 (+218.2%)

Adjusted for splits and dividends.

Volume by month

Buys $312K Sells $33.9M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

OI Opaleye Management Inc. 10% owner 4 filings SB

Sean Brynjelsen President & CEO 3 filings DK

David Krempa Chief Business Officer 3 filings PM

Paul V Maier Director 2 filings JA

Jennifer McKie Adams Director 1 filing JG

James R. Gruber Chief Financial Officer 1 filing

Recent filings

Paul V MaierSALE Director $2.9M
49,872 sh across 2 lots
Exec Aug 28
Filed Aug 31 · 4:06 PM ET Paul V MaierSALE Director $2.9M
49,872 sh across 2 lots
Exec Aug 28
Filed Aug 28 · 4:51 PM ET David KrempaSALE Chief Business Officer $1.6M
25,000 sh × $65.07
Exec Aug 24
Filed Aug 24 · 5:19 PM ET Sean BrynjelsenSALE President & CEO $6.1M
100,000 sh across 4 lots
Exec Aug 19
Filed Aug 20 · 6:26 PM ET Opaleye Management Inc.SALE 10% owner $1.1M
28,315 sh across 2 lots
Exec Jul 14
Filed Jul 17 · 7:12 PM ET † Opaleye Management Inc.SALE 10% owner $1.1M
28,315 sh across 2 lots
Exec Jul 14
Filed Jul 16 · 5:14 PM ET Opaleye Management Inc.SALE 10% owner $4.8M
126,685 sh across 5 lots
Exec Jul 2
Filed Jul 7 · 6:29 PM ET Jennifer McKie AdamsSALE Director $1.6M
50,000 sh × $32.48
Exec Jun 17
Filed Jun 17 · 5:30 PM ET Sean BrynjelsenSALE President & CEO $3.8M
119,852 sh × $31.88
Exec May 28
Filed May 29 · 5:30 PM ET David KrempaSALE Chief Business Officer $3.2M
99,481 sh across 4 lots
Exec May 22
Filed May 27 · 5:30 PM ET James R. GruberSALE Chief Financial Officer $632K
39,082 sh × $16.16
Exec Aug 19 2025
Filed Aug 20 2025 · 5:30 PM ET David KrempaSALE Chief Business Officer $504K
34,000 sh across 3 lots
Exec Jun 12 2025
Filed Jun 16 2025 · 5:30 PM ET Sean BrynjelsenSALE President & CEO $3.6M
209,600 sh across 4 lots
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET Opaleye Management Inc.PURCHASE 10% owner $312K
45,000 sh across 2 lots
Exec Oct 4 2024
Filed Oct 8 2024 · 5:30 PM ET Opaleye Management Inc.PURCHASE 10% owner –
95,000 sh across 2 lots · price not plausible
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET